Shopping Cart 0
Cart Subtotal
AED 0

Global Olopatadine Ophthalmic Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 17910

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 26864

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 35819

Details

Olopatadine eye drops (Pazeo, Patanol, Pataday) are used to treat itchy eyes caused by allergies.

Scope of the Report:

The global Olopatadine Ophthalmic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Olopatadine Ophthalmic.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Olopatadine Ophthalmic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Olopatadine Ophthalmic market by product type and applications/end industries.

Market Segment by Companies, this report covers

Novartis

APOTEX

Teva

Sandoz

Wockhardt

USV Private Limited

Mylan

Akorn

Aurobindo Pharma

Cipla

Alembic Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Ophthalmic solution 0.1%

Ophthalmic solution 0.2%

Ophthalmic solution 0.7%

Market Segment by Applications, can be divided into

Adults

Pediatric patients

READ MORE

Table Of Content

Scope

Table of Contents

1 Olopatadine Ophthalmic Market Overview

1.1 Product Overview and Scope of Olopatadine Ophthalmic

1.2 Classification of Olopatadine Ophthalmic by Types

1.2.1 Global Olopatadine Ophthalmic Revenue Comparison by Types (2019-2024)

1.2.2 Global Olopatadine Ophthalmic Revenue Market Share by Types in 2018

1.2.3 Ophthalmic solution 0.1%

1.2.4 Ophthalmic solution 0.2%

1.2.5 Ophthalmic solution 0.7%

1.3 Global Olopatadine Ophthalmic Market by Application

1.3.1 Global Olopatadine Ophthalmic Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Adults

1.3.3 Pediatric patients

1.4 Global Olopatadine Ophthalmic Market by Regions

1.4.1 Global Olopatadine Ophthalmic Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Olopatadine Ophthalmic Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Olopatadine Ophthalmic Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Olopatadine Ophthalmic Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Olopatadine Ophthalmic Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Olopatadine Ophthalmic Status and Prospect (2014-2024)

1.5 Global Market Size of Olopatadine Ophthalmic (2014-2024)

2 Manufacturers Profiles

2.1 Novartis

2.1.1 Business Overview

2.1.2 Olopatadine Ophthalmic Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Novartis Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.2 APOTEX

2.2.1 Business Overview

2.2.2 Olopatadine Ophthalmic Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 APOTEX Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.3 Teva

2.3.1 Business Overview

2.3.2 Olopatadine Ophthalmic Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Teva Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.4 Sandoz

2.4.1 Business Overview

2.4.2 Olopatadine Ophthalmic Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sandoz Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.5 Wockhardt

2.5.1 Business Overview

2.5.2 Olopatadine Ophthalmic Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Wockhardt Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.6 USV Private Limited

2.6.1 Business Overview

2.6.2 Olopatadine Ophthalmic Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 USV Private Limited Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.7 Mylan

2.7.1 Business Overview

2.7.2 Olopatadine Ophthalmic Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Mylan Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.8 Akorn

2.8.1 Business Overview

2.8.2 Olopatadine Ophthalmic Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Akorn Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.9 Aurobindo Pharma

2.9.1 Business Overview

2.9.2 Olopatadine Ophthalmic Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Aurobindo Pharma Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.10 Cipla

2.10.1 Business Overview

2.10.2 Olopatadine Ophthalmic Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Cipla Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.11 Alembic Pharmaceuticals

2.11.1 Business Overview

2.11.2 Olopatadine Ophthalmic Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Alembic Pharmaceuticals Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

3 Global Olopatadine Ophthalmic Market Competition, by Players

3.1 Global Olopatadine Ophthalmic Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Olopatadine Ophthalmic Players Market Share

3.2.2 Top 10 Olopatadine Ophthalmic Players Market Share

3.3 Market Competition Trend

4 Global Olopatadine Ophthalmic Market Size by Regions

4.1 Global Olopatadine Ophthalmic Revenue and Market Share by Regions

4.2 North America Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

4.3 Europe Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

4.5 South America Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

5 North America Olopatadine Ophthalmic Revenue by Countries

5.1 North America Olopatadine Ophthalmic Revenue by Countries (2014-2019)

5.2 USA Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

5.3 Canada Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

5.4 Mexico Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

6 Europe Olopatadine Ophthalmic Revenue by Countries

6.1 Europe Olopatadine Ophthalmic Revenue by Countries (2014-2019)

6.2 Germany Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

6.3 UK Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

6.4 France Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

6.5 Russia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

6.6 Italy Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Olopatadine Ophthalmic Revenue by Countries

7.1 Asia-Pacific Olopatadine Ophthalmic Revenue by Countries (2014-2019)

7.2 China Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

7.3 Japan Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

7.4 Korea Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

7.5 India Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

8 South America Olopatadine Ophthalmic Revenue by Countries

8.1 South America Olopatadine Ophthalmic Revenue by Countries (2014-2019)

8.2 Brazil Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

8.3 Argentina Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

8.4 Colombia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Olopatadine Ophthalmic by Countries

9.1 Middle East and Africa Olopatadine Ophthalmic Revenue by Countries (2014-2019)

9.2 Saudi Arabia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

9.3 UAE Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

9.4 Egypt Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

9.5 Nigeria Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

9.6 South Africa Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

10 Global Olopatadine Ophthalmic Market Segment by Type

10.1 Global Olopatadine Ophthalmic Revenue and Market Share by Type (2014-2019)

10.2 Global Olopatadine Ophthalmic Market Forecast by Type (2019-2024)

10.3 Ophthalmic solution 0.1% Revenue Growth Rate (2014-2024)

10.4 Ophthalmic solution 0.2% Revenue Growth Rate (2014-2024)

10.5 Ophthalmic solution 0.7% Revenue Growth Rate (2014-2024)

11 Global Olopatadine Ophthalmic Market Segment by Application

11.1 Global Olopatadine Ophthalmic Revenue Market Share by Application (2014-2019)

11.2 Olopatadine Ophthalmic Market Forecast by Application (2019-2024)

11.3 Adults Revenue Growth (2014-2019)

11.4 Pediatric patients Revenue Growth (2014-2019)

12 Global Olopatadine Ophthalmic Market Size Forecast (2019-2024)

12.1 Global Olopatadine Ophthalmic Market Size Forecast (2019-2024)

12.2 Global Olopatadine Ophthalmic Market Forecast by Regions (2019-2024)

12.3 North America Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

12.4 Europe Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

12.6 South America Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Olopatadine Ophthalmic Picture

Table Product Specifications of Olopatadine Ophthalmic

Table Global Olopatadine Ophthalmic and Revenue (Million USD) Market Split by Product Type

Figure Global Olopatadine Ophthalmic Revenue Market Share by Types in 2018

Figure Ophthalmic solution 0.1% Picture

Figure Ophthalmic solution 0.2% Picture

Figure Ophthalmic solution 0.7% Picture

Table Global Olopatadine Ophthalmic Revenue (Million USD) by Application (2014-2024)

Figure Olopatadine Ophthalmic Revenue Market Share by Applications in 2018

Figure Adults Picture

Figure Pediatric patients Picture

Table Global Market Olopatadine Ophthalmic Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (2014-2024)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Olopatadine Ophthalmic Type and Applications

Table Novartis Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table APOTEX Basic Information, Manufacturing Base and Competitors

Table APOTEX Olopatadine Ophthalmic Type and Applications

Table APOTEX Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Teva Basic Information, Manufacturing Base and Competitors

Table Teva Olopatadine Ophthalmic Type and Applications

Table Teva Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Sandoz Basic Information, Manufacturing Base and Competitors

Table Sandoz Olopatadine Ophthalmic Type and Applications

Table Sandoz Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Wockhardt Basic Information, Manufacturing Base and Competitors

Table Wockhardt Olopatadine Ophthalmic Type and Applications

Table Wockhardt Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table USV Private Limited Basic Information, Manufacturing Base and Competitors

Table USV Private Limited Olopatadine Ophthalmic Type and Applications

Table USV Private Limited Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Olopatadine Ophthalmic Type and Applications

Table Mylan Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Akorn Basic Information, Manufacturing Base and Competitors

Table Akorn Olopatadine Ophthalmic Type and Applications

Table Akorn Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors

Table Aurobindo Pharma Olopatadine Ophthalmic Type and Applications

Table Aurobindo Pharma Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Cipla Basic Information, Manufacturing Base and Competitors

Table Cipla Olopatadine Ophthalmic Type and Applications

Table Cipla Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Alembic Pharmaceuticals Olopatadine Ophthalmic Type and Applications

Table Alembic Pharmaceuticals Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Global Olopatadine Ophthalmic Revenue (Million USD) by Players (2014-2019)

Table Global Olopatadine Ophthalmic Revenue Share by Players (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Share by Players in 2017

Figure Global Olopatadine Ophthalmic Revenue Share by Players in 2018

Figure Global Top 5 Players Olopatadine Ophthalmic Revenue Market Share in 2018

Figure Global Top 10 Players Olopatadine Ophthalmic Revenue Market Share in 2018

Figure Global Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Olopatadine Ophthalmic Revenue (Million USD) by Regions (2014-2019)

Table Global Olopatadine Ophthalmic Revenue Market Share by Regions (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Market Share by Regions (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Market Share by Regions in 2018

Figure North America Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Europe Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure South America Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Table North America Olopatadine Ophthalmic Revenue by Countries (2014-2019)

Table North America Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure North America Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure North America Olopatadine Ophthalmic Revenue Market Share by Countries in 2018

Figure USA Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Canada Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Mexico Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Table Europe Olopatadine Ophthalmic Revenue (Million USD) by Countries (2014-2019)

Figure Europe Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure Europe Olopatadine Ophthalmic Revenue Market Share by Countries in 2018

Figure Germany Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure UK Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure France Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Russia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Italy Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Olopatadine Ophthalmic Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Olopatadine Ophthalmic Revenue Market Share by Countries in 2018

Figure China Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Japan Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Korea Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure India Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Table South America Olopatadine Ophthalmic Revenue by Countries (2014-2019)

Table South America Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure South America Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure South America Olopatadine Ophthalmic Revenue Market Share by Countries in 2018

Figure Brazil Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Argentina Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Colombia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Olopatadine Ophthalmic Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Olopatadine Ophthalmic Revenue Market Share by Countries in 2018

Figure Saudi Arabia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure UAE Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Egypt Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Nigeria Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure South Africa Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Table Global Olopatadine Ophthalmic Revenue (Million USD) by Type (2014-2019)

Table Global Olopatadine Ophthalmic Revenue Share by Type (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Share by Type (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Share by Type in 2019

Table Global Olopatadine Ophthalmic Revenue Forecast by Type (2019-2024)

Figure Global Olopatadine Ophthalmic Market Share Forecast by Type (2019-2024)

Figure Global Ophthalmic solution 0.1% Revenue Growth Rate (2014-2019)

Figure Global Ophthalmic solution 0.2% Revenue Growth Rate (2014-2019)

Figure Global Ophthalmic solution 0.7% Revenue Growth Rate (2014-2019)

Table Global Olopatadine Ophthalmic Revenue by Application (2014-2019)

Table Global Olopatadine Ophthalmic Revenue Share by Application (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Share by Application (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Share by Application in 2019

Table Global Olopatadine Ophthalmic Revenue Forecast by Application (2019-2024)

Figure Global Olopatadine Ophthalmic Market Share Forecast by Application (2019-2024)

Figure Global Adults Revenue Growth Rate (2014-2019)

Figure Global Pediatric patients Revenue Growth Rate (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Olopatadine Ophthalmic Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Olopatadine Ophthalmic Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

Figure Europe Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

Figure South America Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Novartis

APOTEX

Teva

Sandoz

Wockhardt

USV Private Limited

Mylan

Akorn

Aurobindo Pharma

Cipla

Alembic Pharmaceuticals

Company Profile

Company Profile Title

Olopatadine eye drops (Pazeo, Patanol, Pataday) are used to treat itchy eyes caused by allergies.

Scope of the Report:

The global Olopatadine Ophthalmic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Olopatadine Ophthalmic.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Olopatadine Ophthalmic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Olopatadine Ophthalmic market by product type and applications/end industries.

Market Segment by Companies, this report covers

Novartis

APOTEX

Teva

Sandoz

Wockhardt

USV Private Limited

Mylan

Akorn

Aurobindo Pharma

Cipla

Alembic Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Ophthalmic solution 0.1%

Ophthalmic solution 0.2%

Ophthalmic solution 0.7%

Market Segment by Applications, can be divided into

Adults

Pediatric patients

READ MORE

Scope

Table of Contents

1 Olopatadine Ophthalmic Market Overview

1.1 Product Overview and Scope of Olopatadine Ophthalmic

1.2 Classification of Olopatadine Ophthalmic by Types

1.2.1 Global Olopatadine Ophthalmic Revenue Comparison by Types (2019-2024)

1.2.2 Global Olopatadine Ophthalmic Revenue Market Share by Types in 2018

1.2.3 Ophthalmic solution 0.1%

1.2.4 Ophthalmic solution 0.2%

1.2.5 Ophthalmic solution 0.7%

1.3 Global Olopatadine Ophthalmic Market by Application

1.3.1 Global Olopatadine Ophthalmic Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Adults

1.3.3 Pediatric patients

1.4 Global Olopatadine Ophthalmic Market by Regions

1.4.1 Global Olopatadine Ophthalmic Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Olopatadine Ophthalmic Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Olopatadine Ophthalmic Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Olopatadine Ophthalmic Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Olopatadine Ophthalmic Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Olopatadine Ophthalmic Status and Prospect (2014-2024)

1.5 Global Market Size of Olopatadine Ophthalmic (2014-2024)

2 Manufacturers Profiles

2.1 Novartis

2.1.1 Business Overview

2.1.2 Olopatadine Ophthalmic Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Novartis Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.2 APOTEX

2.2.1 Business Overview

2.2.2 Olopatadine Ophthalmic Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 APOTEX Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.3 Teva

2.3.1 Business Overview

2.3.2 Olopatadine Ophthalmic Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Teva Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.4 Sandoz

2.4.1 Business Overview

2.4.2 Olopatadine Ophthalmic Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sandoz Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.5 Wockhardt

2.5.1 Business Overview

2.5.2 Olopatadine Ophthalmic Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Wockhardt Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.6 USV Private Limited

2.6.1 Business Overview

2.6.2 Olopatadine Ophthalmic Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 USV Private Limited Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.7 Mylan

2.7.1 Business Overview

2.7.2 Olopatadine Ophthalmic Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Mylan Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.8 Akorn

2.8.1 Business Overview

2.8.2 Olopatadine Ophthalmic Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Akorn Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.9 Aurobindo Pharma

2.9.1 Business Overview

2.9.2 Olopatadine Ophthalmic Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Aurobindo Pharma Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.10 Cipla

2.10.1 Business Overview

2.10.2 Olopatadine Ophthalmic Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Cipla Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

2.11 Alembic Pharmaceuticals

2.11.1 Business Overview

2.11.2 Olopatadine Ophthalmic Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Alembic Pharmaceuticals Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

3 Global Olopatadine Ophthalmic Market Competition, by Players

3.1 Global Olopatadine Ophthalmic Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Olopatadine Ophthalmic Players Market Share

3.2.2 Top 10 Olopatadine Ophthalmic Players Market Share

3.3 Market Competition Trend

4 Global Olopatadine Ophthalmic Market Size by Regions

4.1 Global Olopatadine Ophthalmic Revenue and Market Share by Regions

4.2 North America Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

4.3 Europe Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

4.5 South America Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

5 North America Olopatadine Ophthalmic Revenue by Countries

5.1 North America Olopatadine Ophthalmic Revenue by Countries (2014-2019)

5.2 USA Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

5.3 Canada Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

5.4 Mexico Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

6 Europe Olopatadine Ophthalmic Revenue by Countries

6.1 Europe Olopatadine Ophthalmic Revenue by Countries (2014-2019)

6.2 Germany Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

6.3 UK Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

6.4 France Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

6.5 Russia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

6.6 Italy Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Olopatadine Ophthalmic Revenue by Countries

7.1 Asia-Pacific Olopatadine Ophthalmic Revenue by Countries (2014-2019)

7.2 China Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

7.3 Japan Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

7.4 Korea Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

7.5 India Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

8 South America Olopatadine Ophthalmic Revenue by Countries

8.1 South America Olopatadine Ophthalmic Revenue by Countries (2014-2019)

8.2 Brazil Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

8.3 Argentina Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

8.4 Colombia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Olopatadine Ophthalmic by Countries

9.1 Middle East and Africa Olopatadine Ophthalmic Revenue by Countries (2014-2019)

9.2 Saudi Arabia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

9.3 UAE Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

9.4 Egypt Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

9.5 Nigeria Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

9.6 South Africa Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

10 Global Olopatadine Ophthalmic Market Segment by Type

10.1 Global Olopatadine Ophthalmic Revenue and Market Share by Type (2014-2019)

10.2 Global Olopatadine Ophthalmic Market Forecast by Type (2019-2024)

10.3 Ophthalmic solution 0.1% Revenue Growth Rate (2014-2024)

10.4 Ophthalmic solution 0.2% Revenue Growth Rate (2014-2024)

10.5 Ophthalmic solution 0.7% Revenue Growth Rate (2014-2024)

11 Global Olopatadine Ophthalmic Market Segment by Application

11.1 Global Olopatadine Ophthalmic Revenue Market Share by Application (2014-2019)

11.2 Olopatadine Ophthalmic Market Forecast by Application (2019-2024)

11.3 Adults Revenue Growth (2014-2019)

11.4 Pediatric patients Revenue Growth (2014-2019)

12 Global Olopatadine Ophthalmic Market Size Forecast (2019-2024)

12.1 Global Olopatadine Ophthalmic Market Size Forecast (2019-2024)

12.2 Global Olopatadine Ophthalmic Market Forecast by Regions (2019-2024)

12.3 North America Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

12.4 Europe Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

12.6 South America Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Olopatadine Ophthalmic Picture

Table Product Specifications of Olopatadine Ophthalmic

Table Global Olopatadine Ophthalmic and Revenue (Million USD) Market Split by Product Type

Figure Global Olopatadine Ophthalmic Revenue Market Share by Types in 2018

Figure Ophthalmic solution 0.1% Picture

Figure Ophthalmic solution 0.2% Picture

Figure Ophthalmic solution 0.7% Picture

Table Global Olopatadine Ophthalmic Revenue (Million USD) by Application (2014-2024)

Figure Olopatadine Ophthalmic Revenue Market Share by Applications in 2018

Figure Adults Picture

Figure Pediatric patients Picture

Table Global Market Olopatadine Ophthalmic Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (2014-2024)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Olopatadine Ophthalmic Type and Applications

Table Novartis Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table APOTEX Basic Information, Manufacturing Base and Competitors

Table APOTEX Olopatadine Ophthalmic Type and Applications

Table APOTEX Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Teva Basic Information, Manufacturing Base and Competitors

Table Teva Olopatadine Ophthalmic Type and Applications

Table Teva Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Sandoz Basic Information, Manufacturing Base and Competitors

Table Sandoz Olopatadine Ophthalmic Type and Applications

Table Sandoz Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Wockhardt Basic Information, Manufacturing Base and Competitors

Table Wockhardt Olopatadine Ophthalmic Type and Applications

Table Wockhardt Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table USV Private Limited Basic Information, Manufacturing Base and Competitors

Table USV Private Limited Olopatadine Ophthalmic Type and Applications

Table USV Private Limited Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Olopatadine Ophthalmic Type and Applications

Table Mylan Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Akorn Basic Information, Manufacturing Base and Competitors

Table Akorn Olopatadine Ophthalmic Type and Applications

Table Akorn Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors

Table Aurobindo Pharma Olopatadine Ophthalmic Type and Applications

Table Aurobindo Pharma Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Cipla Basic Information, Manufacturing Base and Competitors

Table Cipla Olopatadine Ophthalmic Type and Applications

Table Cipla Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Alembic Pharmaceuticals Olopatadine Ophthalmic Type and Applications

Table Alembic Pharmaceuticals Olopatadine Ophthalmic Revenue, Gross Margin and Market Share (2017-2018)

Table Global Olopatadine Ophthalmic Revenue (Million USD) by Players (2014-2019)

Table Global Olopatadine Ophthalmic Revenue Share by Players (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Share by Players in 2017

Figure Global Olopatadine Ophthalmic Revenue Share by Players in 2018

Figure Global Top 5 Players Olopatadine Ophthalmic Revenue Market Share in 2018

Figure Global Top 10 Players Olopatadine Ophthalmic Revenue Market Share in 2018

Figure Global Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Olopatadine Ophthalmic Revenue (Million USD) by Regions (2014-2019)

Table Global Olopatadine Ophthalmic Revenue Market Share by Regions (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Market Share by Regions (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Market Share by Regions in 2018

Figure North America Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Europe Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure South America Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Table North America Olopatadine Ophthalmic Revenue by Countries (2014-2019)

Table North America Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure North America Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure North America Olopatadine Ophthalmic Revenue Market Share by Countries in 2018

Figure USA Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Canada Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Mexico Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Table Europe Olopatadine Ophthalmic Revenue (Million USD) by Countries (2014-2019)

Figure Europe Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure Europe Olopatadine Ophthalmic Revenue Market Share by Countries in 2018

Figure Germany Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure UK Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure France Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Russia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Italy Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Olopatadine Ophthalmic Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Olopatadine Ophthalmic Revenue Market Share by Countries in 2018

Figure China Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Japan Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Korea Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure India Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Table South America Olopatadine Ophthalmic Revenue by Countries (2014-2019)

Table South America Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure South America Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure South America Olopatadine Ophthalmic Revenue Market Share by Countries in 2018

Figure Brazil Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Argentina Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Colombia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Olopatadine Ophthalmic Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Olopatadine Ophthalmic Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Olopatadine Ophthalmic Revenue Market Share by Countries in 2018

Figure Saudi Arabia Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure UAE Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Egypt Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure Nigeria Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Figure South Africa Olopatadine Ophthalmic Revenue and Growth Rate (2014-2019)

Table Global Olopatadine Ophthalmic Revenue (Million USD) by Type (2014-2019)

Table Global Olopatadine Ophthalmic Revenue Share by Type (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Share by Type (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Share by Type in 2019

Table Global Olopatadine Ophthalmic Revenue Forecast by Type (2019-2024)

Figure Global Olopatadine Ophthalmic Market Share Forecast by Type (2019-2024)

Figure Global Ophthalmic solution 0.1% Revenue Growth Rate (2014-2019)

Figure Global Ophthalmic solution 0.2% Revenue Growth Rate (2014-2019)

Figure Global Ophthalmic solution 0.7% Revenue Growth Rate (2014-2019)

Table Global Olopatadine Ophthalmic Revenue by Application (2014-2019)

Table Global Olopatadine Ophthalmic Revenue Share by Application (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Share by Application (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue Share by Application in 2019

Table Global Olopatadine Ophthalmic Revenue Forecast by Application (2019-2024)

Figure Global Olopatadine Ophthalmic Market Share Forecast by Application (2019-2024)

Figure Global Adults Revenue Growth Rate (2014-2019)

Figure Global Pediatric patients Revenue Growth Rate (2014-2019)

Figure Global Olopatadine Ophthalmic Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Olopatadine Ophthalmic Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Olopatadine Ophthalmic Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

Figure Europe Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

Figure South America Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Olopatadine Ophthalmic Revenue Market Forecast (2019-2024)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Novartis

APOTEX

Teva

Sandoz

Wockhardt

USV Private Limited

Mylan

Akorn

Aurobindo Pharma

Cipla

Alembic Pharmaceuticals